The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
Akao, 2014, Extracellular disposal of tumor-suppressor miRs-145 and -34a via microvesicles and 5-FU resistance of human colon cancer cells, Int. J. Mol. Sci., 15, 1392, 10.3390/ijms15011392
Alaoui-Jamali, 2004, Prediction of drug sensitivity and drug resistance in cancer by transcriptional and proteomic profiling, Drug Resist. Updat., 7, 245, 10.1016/j.drup.2004.06.004
Alfarouk, 2015, Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp, Cancer Cell Int., 15, 71, 10.1186/s12935-015-0221-1
Alharbi, 2020, miRNa signature in small extracellular vesicles and their association with platinum resistance and cancer recurrence in ovarian cancer, Nanomedicine, 28
An, 2017, Regulation of multidrug resistance by microRNAs in anti-cancer therapy, Acta Pharm. Sin. B, 7, 38, 10.1016/j.apsb.2016.09.002
Assaraf, 2019, The multi-factorial nature of clinical multidrug resistance in cancer, Drug Resist. Updat., 46, 10.1016/j.drup.2019.100645
Au Yeung, 2016, Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1, Nat. Commun., 7, 11150, 10.1038/ncomms11150
Aung, 2011, Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3, Proc. Natl. Acad. Sci. USA, 108, 15336, 10.1073/pnas.1102855108
Bailey, 2021, Tracking cancer evolution through the disease course, Cancer Discov., 11, 916, 10.1158/2159-8290.CD-20-1559
Bandari, 2020, Therapy-induced chemoexosomes: sinister small extracellular vesicles that support tumor survival and progression, Cancer Lett., 493, 113, 10.1016/j.canlet.2020.08.022
Barzegar, 2021, AML-derived extracellular vesicles confer de novo chemoresistance to leukemic myeloblast cells by promoting drug export genes expression and ROS inhibition, Iran. J. Pharm. Res., 20, 384
Bebawy, 2009, Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells, Leukemia, 23, 1643, 10.1038/leu.2009.76
Becker, 2016, Extracellular vesicles in cancer: cell-to-cell mediators of metastasis, Cancer Cell, 30, 836, 10.1016/j.ccell.2016.10.009
Berguetti, 2019, TNF-alpha modulates P-glycoprotein expression and contributes to cellular proliferation via extracellular vesicles, Cells, 8, 10.3390/cells8050500
Binenbaum, 2018, Transfer of miRNA in macrophage-derived exosomes induces drug resistance in pancreatic adenocarcinoma, Cancer Res., 78, 5287, 10.1158/0008-5472.CAN-18-0124
Bliss, 2016, Mesenchymal stem cell-derived exosomes stimulate cycling quiescence and early breast cancer dormancy in bone marrow, Cancer Res., 76, 5832, 10.1158/0008-5472.CAN-16-1092
Boussadia, 2018, Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules, J. Exp. Clin. Cancer Res., 37, 245, 10.1186/s13046-018-0915-z
Bouvy, 2017, Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo, Leuk. Res., 62, 70, 10.1016/j.leukres.2017.09.014
Bram, 2009, Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance, Neoplasia, 11, 1359, 10.1593/neo.91314
Bu, 2020, Functional diversity of cancer-associated fibroblasts in modulating drug resistance, Cancer Sci., 111, 3468, 10.1111/cas.14578
Buckens, 2020, The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment, Expert Opin. Investig. Drugs, 29, 567, 10.1080/13543784.2020.1762566
Cao, 2017, Exosomal DNMT1 mediates cisplatin resistance in ovarian cancer, Cell Biochem. Funct., 35, 296, 10.1002/cbf.3276
Cao, 2019, Exosome-derived miR-27a produced by PSC-27cells contributes to prostate cancer chemoresistance through p53, Biochem. Biophys. Res. Commun., 515, 345, 10.1016/j.bbrc.2019.05.120
Cesi, 2018, A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells, Mol. Cancer, 17, 145, 10.1186/s12943-018-0886-x
Challagundla, 2015, Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy, J. Natl. Cancer Inst., 107, 10.1093/jnci/djv135
Chang, 2021, KRAS-dependent cancer cells promote survival by producing exosomes enriched in Survivin, Cancer Lett., 517, 66, 10.1016/j.canlet.2021.05.031
Chen, 2016, Long non-coding RNAs in anti-cancer drug resistance, Oncotarget, 8
Chen, 2006, The role of the VPS4A-exosome pathway in the intrinsic egress route of a DNA-binding anticancer drug, Pharm. Res., 23, 1687, 10.1007/s11095-006-9043-0
Chen, 2014, Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs, Tumour Biol., 35, 9649, 10.1007/s13277-014-2242-0
Cheng, 2014, Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood, J. Extracell. Vesicles, 3, 10.3402/jev.v3.23743
Cloutier, 2008, Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-x, J. Biol. Chem., 283, 21315, 10.1074/jbc.M800353200
Colombo, 2014, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles, Annu. Rev. Cell. Dev. Biol., 30, 255, 10.1146/annurev-cellbio-101512-122326
Connors, 2020, International liquid biopsy standardization alliance white paper, Crit. Rev. Oncol. Hematol., 156, 10.1016/j.critrevonc.2020.103112
Corcoran, 2012, Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes, PLoS One, 7, 10.1371/journal.pone.0050999
Corcoran, 2014, miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression, Prostate, 74, 1320, 10.1002/pros.22848
Correia, 2012, The tumor microenvironment is a dominant force in multidrug resistance, Drug Resist. Updat., 15, 39, 10.1016/j.drup.2012.01.006
Cvjetkovic, 2016, Detailed analysis of protein topology of extracellular vesicles-evidence of unconventional membrane protein orientation, Sci. Rep., 6, 36338, 10.1038/srep36338
Dagogo-Jack, 2018, Tumour heterogeneity and resistance to cancer therapies, Nat. Rev. Clin. Oncol., 15, 81, 10.1038/nrclinonc.2017.166
Deng, 2020, Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells, Int. J. Cancer, 146, 1700, 10.1002/ijc.32608
Domenichini, 2019, ABC transporters as cancer drivers: potential functions in cancer development, Biochim. Biophys. Acta Gen. Subj., 1863, 52, 10.1016/j.bbagen.2018.09.019
Dong, 2019, Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin, Onco Targets Ther., 12, 1947, 10.2147/OTT.S186922
Dong, 2018, Exosome-mediated transfer of lncRNASNHG14 promotes trastuzumab chemoresistance in breast cancer, Int. J. Oncol., 53, 1013
Dong, 2021, Pre-metastatic Niche formation in different organs induced by tumor extracellular vesicles, Front. Cell. Dev. Biol., 9, 10.3389/fcell.2021.733627
Dong, 2014, Tumor endothelial expression of P-glycoprotein upon microvesicular transfer of TrpC5 derived from adriamycin-resistant breast cancer cells, Biochem. Biophys. Res. Commun., 446, 85, 10.1016/j.bbrc.2014.02.076
Dorayappan, 2018, Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins, Oncogene, 37, 3806, 10.1038/s41388-018-0189-0
Endzelins, 2018, Extracellular vesicles derived from hypoxic colorectal cancer cells confer metastatic phenotype to non-metastatic cancer cells, Anticancer Res., 38, 5139, 10.21873/anticanres.12836
Erin, 2020, Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance, Drug Resist. Updat., 53, 10.1016/j.drup.2020.100715
Faict, 2019, The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma, Cancers, 11, 10.3390/cancers11121823
Fan, 2018, Chemoresistance transmission via exosome-mediated EphA2 transfer in pancreatic cancer, Theranostics, 8, 5986, 10.7150/thno.26650
Fang, 2019, Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer, Exp. Cell. Res., 383, 10.1016/j.yexcr.2019.111543
Federici, 2014, Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin, PLoS One, 9, 10.1371/journal.pone.0088193
Fontana, 2021, Extracellular vesicles: emerging modulators of cancer drug resistance, Cancers, 13, 10.3390/cancers13040749
Freitas, 2014, Therapy-induced enrichment of putative lung cancer stem-like cells, Int. J. Cancer, 134, 1270, 10.1002/ijc.28478
Gandham, 2020, Technologies and standardization in research on extracellular vesicles, Trends Biotechnol., 38, 1066, 10.1016/j.tibtech.2020.05.012
Gao, 2021, Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function, Drug Resist. Updat., 57, 10.1016/j.drup.2021.100770
Garg, 2016, Survivin: a unique target for tumor therapy, Cancer Cell Int., 16, 49, 10.1186/s12935-016-0326-1
Garnier-Suillerot, 2001, Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action, Curr. Med. Chem., 8, 51, 10.2174/0929867013373967
Giovannetti, 2012, Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice, Crit. Rev. Oncol. Hematol., 81, 103, 10.1016/j.critrevonc.2011.03.010
Goler-Baron, 2011, Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance, PLoS One, 6, 10.1371/journal.pone.0016007
Goncalves, 2021, Impact of cancer metabolism on therapy resistance - clinical implications, Drug Resist. Updat.
Gong, 2014, Microparticles mediate the intercellular regulation of microRNA-503 and proline-rich tyrosine kinase 2 to alter the migration and invasion capacity of breast cancer cells, Front. Oncol., 4, 220, 10.3389/fonc.2014.00220
Gong, 2013, Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance, Eur. J. Pharmacol., 721, 116, 10.1016/j.ejphar.2013.09.044
Haderk, 2017, Tumor-derived exosomes modulate PD-L1 expression in monocytes, Sci. Immunol., 2, 10.1126/sciimmunol.aah5509
Han, 2019, Extracellular vesicles in the tumor microenvironment: old stories, but new tales, Mol. Cancer, 18, 59, 10.1186/s12943-019-0980-8
He, 2020, Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma, Int. J. Cancer, 146, 1052, 10.1002/ijc.32543
Hernandez-Barranco, 2021, Could extracellular vesicles contribute to generation or awakening of "sleepy" metastatic niches?, Front. Cell. Dev. Biol., 9, 10.3389/fcell.2021.625221
Herrmann, 2021, Extracellular vesicles as a next-generation drug delivery platform, Nat. Nanotechnol., 16, 748, 10.1038/s41565-021-00931-2
Hoshino, 2020, Extracellular vesicle and particle biomarkers define multiple human cancers, Cell, 182, 1044, 10.1016/j.cell.2020.07.009
Hu, 2019, CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer, Mol. Cancer, 18, 91, 10.1186/s12943-019-1019-x
Hu, 2020, Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology, Mol. Cancer, 19, 102, 10.1186/s12943-020-01199-1
Hu, 2015, Fibroblast-derived exosomes contribute to chemoresistance through priming cancer stem cells in colorectal cancer, PLoS One, 10
Hu, 2019, Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance, Oncogene, 38, 1951, 10.1038/s41388-018-0557-9
Icard, 2018, How the Warburg effect supports aggressiveness and drug resistance of cancer cells?, Drug Resist. Updat., 38, 1, 10.1016/j.drup.2018.03.001
Ifergan, 2005, Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance, Cancer Res., 65, 10952, 10.1158/0008-5472.CAN-05-2021
Iorio, 2012, MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review, EMBO Mol. Med., 4, 143, 10.1002/emmm.201100209
Jaiswal, 2012, Microparticle-associated nucleic acids mediate trait dominance in cancer, FASEB J., 26, 420, 10.1096/fj.11-186817
Jaiswal, 2013, Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells, PLoS One, 8, 10.1371/journal.pone.0061515
Ji, 2015, Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer, Cell Cycle, 14, 2473, 10.1080/15384101.2015.1005530
Jin, 2019, A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer, Cancer Chemother. Pharmacol., 84, 315, 10.1007/s00280-019-03867-6
Jung, 2015, Phospholipids of tumor extracellular vesicles stratify gefitinib-resistant nonsmall cell lung cancer cells from gefitinib-sensitive cells, Proteomics, 15, 824, 10.1002/pmic.201400243
Kadel, 2019, Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy, Cell Biol. Toxicol., 35, 407, 10.1007/s10565-019-09461-z
Kanada, 2016, Signaling by extracellular vesicles advances cancer hallmarks, Trends Cancer, 2, 84, 10.1016/j.trecan.2015.12.005
Kanlikilicer, 2018, Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer, EBioMedicine, 38, 100, 10.1016/j.ebiom.2018.11.004
Kato, 2015, Serum exosomal P-glycoprotein is a potential marker to diagnose docetaxel resistance and select a taxoid for patients with prostate cancer, Urol. Oncol., 33, 385, 10.1016/j.urolonc.2015.04.019
Kaufman, 2006, Coexistence of multiple mechanisms of PT523 resistance in human leukemia cells harboring 3 reduced folate carrier alleles: transcriptional silencing, inactivating mutations, and allele loss, Blood, 107, 3288, 10.1182/blood-2005-10-4048
Khan, 2009, Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential, Br. J. Cancer, 100, 1073, 10.1038/sj.bjc.6604978
Khan, 2011, Survivin is released from cancer cells via exosomes, Apoptosis, 16, 1, 10.1007/s10495-010-0534-4
Khan, 2012, Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer, PLoS One, 7, 10.1371/journal.pone.0046737
King, 2012, Hypoxic enhancement of exosome release by breast cancer cells, BMC Cancer, 12, 421, 10.1186/1471-2407-12-421
Koren, 2016, The bad seed: cancer stem cells in tumor development and resistance, Drug Resist. Updat., 28, 1, 10.1016/j.drup.2016.06.006
Kreger, 2016, The enrichment of survivin in exosomes from breast cancer cells treated with paclitaxel promotes cell survival and chemoresistance, Cancers, 8, 10.3390/cancers8120111
Kwok, 2019, Transfer of extracellular vesicle-associated-RNAs induces drug resistance in ALK-translocated lung adenocarcinoma, Cancers, 11, 10.3390/cancers11010104
Layoun, 2011, Enrichment and trafficking of BCR-ABL oncoprotein in exosomes promotes the IL-3 independent proliferation of bystander cells, Blood, 118, 10.1182/blood.V118.21.3751.3751
Leal-Orta, 2019, Role of PI3K/Akt on migration and invasion of MCF10A cells treated with extracellular vesicles from MDA-MB-231 cells stimulated with linoleic acid, J. Cell Commun. Signal., 13, 235, 10.1007/s12079-018-0490-2
Leonetti, 2019, MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: current implications and future directions, Drug Resist. Updat., 42, 1, 10.1016/j.drup.2018.11.002
Levchenko, 2005, Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells, Proc. Natl. Acad. Sci. USA, 102, 1933, 10.1073/pnas.0401851102
Levin, 2021, Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance, Cancer Cell Int., 21, 53, 10.1186/s12935-021-01746-w
Li, 2020, EGFR-rich extracellular vesicles derived from highly metastatic nasopharyngeal carcinoma cells accelerate tumour metastasis through PI3K/AKT pathway-suppressed ROS, J. Extracell. Vesicles, 10, 10.1002/jev2.12003
Li, 2021, The emerging role of exosomes in cancer chemoresistance, Front. Cell. Dev. Biol., 9
Li, 2021, DNA repair pathways in cancer therapy and resistance, Front. Pharmacol., 11, 10.3389/fphar.2020.629266
Li, 2016, Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies, Drug Resist. Updat., 27, 14, 10.1016/j.drup.2016.05.001
Li, 2019, Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFkappaB/c-Myc signaling in female esophageal carcinoma, Mol. Cancer, 18, 22, 10.1186/s12943-019-0949-7
Lima, 2011, MicroRNA regulation of core apoptosis pathways in cancer, Eur. J. Cancer, 47, 163, 10.1016/j.ejca.2010.11.005
Lima, 2004, Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells, Cancer Gene Ther., 11, 309, 10.1038/sj.cgt.7700706
Liu, 2017, Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma, Acta Biochim. Biophys. Sin., 49, 808, 10.1093/abbs/gmx078
Lobb, 2017, Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance, Int. J. Cancer, 141, 614, 10.1002/ijc.30752
Logozzi, 2018, Microenvironmental pH and exosome levels interplay in human cancer cell lines of different histotypes, Cancers, 10, 10.3390/cancers10100370
Logozzi, 2019, Extracellular acidity and increased exosome release as key phenotypes of malignant tumors, Cancer Metastasis Rev., 38, 93, 10.1007/s10555-019-09783-8
Lopes-Rodrigues, 2016, Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells, Biochim. Biophys. Acta, 1860, 618, 10.1016/j.bbagen.2015.12.011
Lou, 2015, Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma, J. Hematol. Oncol., 8, 122, 10.1186/s13045-015-0220-7
Lu, 2013, Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways, Pharmacol. Res., 76, 77, 10.1016/j.phrs.2013.07.009
Lu, 2017, A novel mechanism governing the transcriptional regulation of ABC transporters in MDR cancer cells, Drug Deliv. Transl. Res., 7, 276, 10.1007/s13346-016-0353-4
Lv, 2014, Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein, Tumour Biol., 35, 10773, 10.1007/s13277-014-2377-z
Ma, 2014, Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance, Proc. Natl. Acad. Sci. USA, 111, 6389, 10.1073/pnas.1400272111
Ma, 2019, Exosomal transfer of cisplatin-induced miR-425-3p confers cisplatin resistance in NSCLC through activating autophagy, Int. J. Nanomed., 14, 8121, 10.2147/IJN.S221383
Mathieu, 2019, Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication, Nat. Cell Biol., 21, 9, 10.1038/s41556-018-0250-9
Meng, 2016, Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer, Oncotarget, 7, 16923, 10.18632/oncotarget.7850
Min, 2018, Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365, Exp. Cell Res., 362, 386, 10.1016/j.yexcr.2017.12.001
Mir, 2020, Extracellular vesicles as delivery vehicles of specific cellular cargo, Cells, 9, 10.3390/cells9071601
Mollaei, 2021, Chemotherapeutic drugs: cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?, Transl. Oncol., 14, 10.1016/j.tranon.2021.101056
Moore, 2010, An alternative splicing network links cell-cycle control to apoptosis, Cell, 142, 625, 10.1016/j.cell.2010.07.019
Muralidharan-Chari, 2016, Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells, Oncotarget, 7, 50365, 10.18632/oncotarget.10395
Najafi, 2019, Cancer stem cell (a)symmetry & plasticity: tumorigenesis and therapy relevance, Life Sci., 10.1016/j.lfs.2019.05.076
Nik Mohamed Kamal, 2019, Non-exosomal and exosomal circulatory MicroRNAs: which are more valid as biomarkers?, Front. Pharmacol., 10, 1500, 10.3389/fphar.2019.01500
Ning, 2017, UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer, J. Surg. Oncol., 115, 932, 10.1002/jso.24614
Nussinov, 2021, Anticancer drug resistance: an update and perspective, Drug Resist. Updat., 59, 10.1016/j.drup.2021.100796
Ozawa, 2018, Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells, Breast Cancer Res. Treat., 172, 713, 10.1007/s10549-018-4925-5
Ozyerli-Goknar, 2021, Epigenetic deregulation of apoptosis in cancers, Cancers, 13, 10.3390/cancers13133210
Parolini, 2009, Microenvironmental pH is a key factor for exosome traffic in tumor cells, J. Biol. Chem., 284, 34211, 10.1074/jbc.M109.041152
Patel, 2017, Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK, Br. J. Cancer, 116, 609, 10.1038/bjc.2017.18
Pavlyukov, 2018, Apoptotic cell-derived extracellular vesicles promote malignancy of glioblastoma via intercellular transfer of splicing factors, Cancer Cell, 34, 119, 10.1016/j.ccell.2018.05.012
Peinado, 2012, Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET, Nat. Med., 18, 883, 10.1038/nm.2753
Pokharel, 2016, The role of CD44 and ERM proteins in expression and functionality of P-glycoprotein in breast cancer cells, Molecules, 21, 290, 10.3390/molecules21030290
Pokharel, 2014, Proteome analysis of multidrug-resistant, breast cancer-derived microparticles, J. Extracell. Vesicles, 3, 10.3402/jev.v3.24384
Poupardin, 2021, Adherence to minimal experimental requirements for defining extracellular vesicles and their functions, Adv. Drug Deliv. Rev., 176, 10.1016/j.addr.2021.113872
Pucci, 2016, SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions, Science, 352, 242, 10.1126/science.aaf1328
Qiao, 2009, Targeting apoptosis as an approach for gastrointestinal cancer therapy, Drug Resist. Updat., 12, 55, 10.1016/j.drup.2009.02.002
Qin, 2020, Emerging role of tumor cell plasticity in modifying therapeutic response, Signal Transduct. Target Ther., 5, 228, 10.1038/s41392-020-00313-5
Qin, 2019, Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5, Genome Biol., 20, 12, 10.1186/s13059-018-1604-0
Qu, 2016, Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA, Cancer Cell, 29, 653, 10.1016/j.ccell.2016.03.004
Rapisarda, 2009, Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies, Drug Resist. Updat., 12, 74, 10.1016/j.drup.2009.03.002
Ren, 2018, Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19, Theranostics, 8, 3932, 10.7150/thno.25541
Richards, 2017, Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells, Oncogene, 36, 1770, 10.1038/onc.2016.353
Rolfo, 2021, Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer, J. Thorac. Oncol., 16, 1647, 10.1016/j.jtho.2021.06.017
Roos, 2018, XRCC3 contributes to temozolomide resistance of glioblastoma cells by promoting DNA double-strand break repair, Cancer Lett., 424, 119, 10.1016/j.canlet.2018.03.025
Safaei, 2005, Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells, Mol. Cancer Ther., 4, 1595, 10.1158/1535-7163.MCT-05-0102
Sansone, 2017, Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer, Proc. Natl. Acad. Sci. USA, 114, E9066, 10.1073/pnas.1704862114
Seca, 2013, Targeting miR-21 induces autophagy and chemosensitivity of leukemia cells, Curr. Drug Targets, 14, 1135, 10.2174/13894501113149990185
Seca, 2014, MicroRNAs in cancer drug resistance and drug sensitivity, 251
Shahar, 2020, Inhibiting the inhibitors: targeting anti-apoptotic proteins in cancer and therapy resistance, Drug Resist. Updat., 52, 10.1016/j.drup.2020.100712
Sharifzad, 2019, Glioblastoma cancer stem cell biology: potential theranostic targets, Drug Resist. Updat., 42, 35, 10.1016/j.drup.2018.03.003
Shinohara, 2017, Regulated polarization of tumor-associated macrophages by miR-145 via colorectal cancer-derived extracellular vesicles, J. Immunol., 199, 1505, 10.4049/jimmunol.1700167
Siravegna, 2017, Integrating liquid biopsies into the management of cancer, Nat. Rev. Clin. Oncol., 14, 531, 10.1038/nrclinonc.2017.14
Sousa, 2021, Different ability of multidrug-resistant and -sensitive counterpart cells to release and capture extracellular vesicles, Cells, 10, 10.3390/cells10112886
Sousa, 2015, Intercellular transfer of cancer drug resistance traits by extracellular vesicles, Trends Mol. Med., 21, 595, 10.1016/j.molmed.2015.08.002
Stefanius, 2019, Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformation, Elife, 8, 10.7554/eLife.40226
Stevic, 2018, Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial, BMC Med., 16, 179, 10.1186/s12916-018-1163-y
Takahashi, 2014, Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer, FEBS Open Biol., 4, 458, 10.1016/j.fob.2014.04.007
Takahashi, 2014, Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy, Mol. Cancer Res., 12, 1377, 10.1158/1541-7786.MCR-13-0636
Tang, 2019, Overexpression of serum exosomal HOTAIR is correlated with poor survival and poor response to chemotherapy in breast cancer patients, J. Biosci., 44, 10.1007/s12038-019-9861-y
Taylor, 2015, Microenvironment acidity as a major determinant of tumor chemoresistance: proton pump inhibitors (PPIs) as a novel therapeutic approach, Drug Resist. Updat., 23, 69, 10.1016/j.drup.2015.08.004
Theile, 2021, Acquired ABC-transporter overexpression in cancer cells: transcriptional induction or Darwinian selection?, Naunyn Schmiedebergs Arch. Pharmacol., 394, 1621, 10.1007/s00210-021-02112-3
Thery, 2018, Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines, J. Extracell. Vesicles, 7, 10.1080/20013078.2018.1535750
Torreggiani, 2016, Multimodal transfer of MDR by exosomes in human osteosarcoma, Int. J. Oncol., 49, 189, 10.3892/ijo.2016.3509
Turajlic, 2019, Resolving genetic heterogeneity in cancer, Nat. Rev. Genet., 20, 404, 10.1038/s41576-019-0114-6
Uchihara, 2020, Extracellular vesicles from cancer-associated fibroblasts containing annexin A6 induces FAK-YAP activation by stabilizing beta1 integrin, enhancing drug resistance, Cancer Res., 80, 3222, 10.1158/0008-5472.CAN-19-3803
van Niel, 2018, Shedding light on the cell biology of extracellular vesicles, Nat. Rev. Mol. Cell Biol., 19, 213, 10.1038/nrm.2017.125
Vasconcelos, 2019, Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance, Drug Resist. Updat., 47, 10.1016/j.drup.2019.100647
Walker, 2019, Exosomes from differentially activated macrophages influence dormancy or resurgence of breast cancer cells within bone marrow stroma, Cell Death Dis., 10, 59, 10.1038/s41419-019-1304-z
Wang, 2019, Exosome-mediated transfer of lncRNA HOTTIP promotes cisplatin resistance in gastric cancer cells by regulating HMGA1/miR-218 axis, Onco Targets Ther., 12, 11325, 10.2147/OTT.S231846
Wang, 2021, Multidrug resistance proteins (MRPs): structure, function and the overcoming of cancer multidrug resistance, Drug Resist. Updat., 54, 10.1016/j.drup.2021.100743
Wang, 2014, Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis, Proc. Natl. Acad. Sci. USA, 111, E3234
Wei, 2017, Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p, Mol. Cancer, 16, 132, 10.1186/s12943-017-0694-8
Wei, 2014, Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells, Breast Cancer Res. Treat., 147, 423, 10.1007/s10549-014-3037-0
Wijdeven, 2016, Old drugs, novel ways out: drug resistance toward cytotoxic chemotherapeutics, Drug Resist. Updat., 28, 65, 10.1016/j.drup.2016.07.001
Wu, 2020, Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1, Cell Death Dis., 11, 801, 10.1038/s41419-020-02962-4
Xavier, 2020, The role of extracellular vesicles in the hallmarks of cancer and drug resistance, Cells, 9, 10.3390/cells9051141
Xavier, 2021, Chitinase 3-like-1 and fibronectin in the cargo of extracellular vesicles shed by human macrophages influence pancreatic cancer cellular response to gemcitabine, Cancer Lett., 501, 210, 10.1016/j.canlet.2020.11.013
Xu, 2019, Exosome-transmitted PSMA3 and PSMA3-AS1 promote proteasome inhibitor resistance in multiple myeloma, Clin. Cancer Res., 25, 1923, 10.1158/1078-0432.CCR-18-2363
Xu, 2018, Extracellular vesicles in cancer - implications for future improvements in cancer care, Nat. Rev. Clin. Oncol., 15, 617, 10.1038/s41571-018-0036-9
Yanez-Mo, 2015, Biological properties of extracellular vesicles and their physiological functions, J. Extracell. Vesicles, 4, 27066, 10.3402/jev.v4.27066
Yin, 2021, Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p, Theranostics, 11, 1763, 10.7150/thno.47057
Yin, 2012, Secretion of annexin A3 from ovarian cancer cells and its association with platinum resistance in ovarian cancer patients, J. Cell Mol. Med., 16, 337, 10.1111/j.1582-4934.2011.01316.x
Yin, 2019, Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma, EBioMedicine, 42, 238, 10.1016/j.ebiom.2019.03.016
Yu, 2016, Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222, Tumour Biol., 37, 3227, 10.1007/s13277-015-4161-0
Yue, 2019, Hypoxic glioma cell-secreted exosomal miR-301a activates Wnt/beta-catenin signaling and promotes radiation resistance by targeting TCEAL7, Mol. Ther., 27, 1939, 10.1016/j.ymthe.2019.07.011
Zeng, 2018, Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma, Cancer Lett., 436, 10, 10.1016/j.canlet.2018.08.004
Zhang, 2014, Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance, Eur. J. Pharmacol., 738, 83, 10.1016/j.ejphar.2014.05.026
Zhang, 2020, CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer, Mol. Cancer, 19, 43, 10.1186/s12943-020-01168-8
Zhang, 2021, Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2/HEPH axis, J. Cell Mol. Med., 25, 3699, 10.1111/jcmm.15765
Zhang, 2019, Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells, J. Exp. Clin. Cancer Res., 38, 320, 10.1186/s13046-019-1314-9
Zhang, 2021, CAFs-derived exosomal miRNA-130a confers cisplatin resistance of NSCLC cells through PUM2-dependent packaging, Int. J. Nanomed., 16, 561, 10.2147/IJN.S271976
Zhang, 2018, Exosome-mediated transfer of lncRNA RP11838N2.4 promotes erlotinib resistance in non-small cell lung cancer, Int. J. Oncol., 53, 527
Zhang, 2017, Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells, Nucleic Acids Res., 45, 5930, 10.1093/nar/gkx317
Zhang, 2019, Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma, J. Exp. Clin. Cancer Res., 38, 166, 10.1186/s13046-019-1139-6
Zhao, 2021, Effects of ATP-binding cassette transporter G2 in extracellular vesicles on drug resistance of laryngeal cancer cells in in vivo and in vitro, Oncol. Lett., 21, 364, 10.3892/ol.2021.12625
Zheng, 2017, Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells, J. Exp. Clin. Cancer Res., 36, 53, 10.1186/s13046-017-0528-y
Zhitomirsky, 2017, Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis, Oncotarget, 8, 45117, 10.18632/oncotarget.15155
Zhitomirsky, 2015, Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance, Oncotarget, 6, 1143, 10.18632/oncotarget.2732
Zhitomirsky, 2016, Lysosomes as mediators of drug resistance in cancer, Drug Resist. Updat., 24, 23, 10.1016/j.drup.2015.11.004
Zhitomirsky, 2018, Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity, Cell Death Dis., 9, 1191, 10.1038/s41419-018-1227-0